triazolam has been researched along with Bipolar Disorder in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Bipolar Disorder: A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weilburg, JB | 1 |
| Sachs, G | 1 |
| Falk, WE | 1 |
1 other study available for triazolam and Bipolar Disorder
| Article | Year |
|---|---|
Triazolam-induced brief episodes of secondary mania in a depressed patient.
Topics: Aged; Bipolar Disorder; Depressive Disorder; Female; Humans; Triazolam | 1987 |